
Pharmacally
Kerendia
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Kerendia
New Drug ApprovalFDA Approves Kerendia for Type 1 Diabetes-Associated CKDThe FDA approved Bayer’s Kerendia (finerenone) for adults with chronic kidney disease associated with type 1 diabetes.Fact-Checked
New Drug ApprovalBayer Wins NMPA Approval for Kerendia in HFmrEF/HFpEFBayer has secured Chinese approval for Kerendia® (finerenone) in adults with symptomatic heart failure and LVEF ≥40%, covering HFmrEF and HFpEF.Fact-Checked
Health TidingsFDA Grants Priority Review to Bayer’s Kerendia for T1D-Associated CKDBayer has received FDA Priority Review for its supplemental New Drug Application seeking expanded approval of Kerendia (finerenone) in adults with chronic kidney disease (CKD) associated with type…Fact-Checked
Health TidingsEU Expands Kerendia Label: Bayer’s Finerenone Approved for Broader Heart Failure PopulationThe EU expands Kerendia’s label to heart failure with LVEF ≥40%, with Phase III data supporting significant reductions in cardiovascular death and heart failure events.Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.